Indogulf Cropsciences Limited has made available the audio recording of its conference call with analysts and investors. The call was held on Tuesday, August 18, 2026, to discuss the company's un-audited standalone and consolidated financial results and performance for the first quarter of FY2026-27.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR"). The company submitted the link to the listing operation departments of both the BSE Limited and the National Stock Exchange of India Limited.

Sakshi Jain, Company Secretary and Compliance Officer of Indogulf Cropsciences, signed the communication on behalf of the company. The filing serves as a record for the exchanges and provides stakeholders access to the management's commentary on the recent quarterly performance.

Indogulf Cropsciences reported a contraction in profitability during the first quarter of FY27, with net profit falling 38% year-on-year to ₹24.14 Mn. Operating revenue declined 11% to ₹1,685.45 Mn from ₹1,893.72 Mn in Q1FY26, reflecting broader challenges in the agrochemical segment. EBITDA decreased 4% to ₹95.55 Mn, while gross profit rose 12% to ₹465.78 Mn, indicating some margin resilience despite lower top-line growth.

The company’s full-year performance for FY26 showed stronger momentum, with net profit rising 27% to ₹400 Mn and revenue growing 19% to ₹7,046 Mn. This contrast between the strong annual close and the soft start to FY27 highlights seasonal or cyclical pressures in the current quarter. Gross margin expanded to 40.2% in Q1FY27 compared to 31.0% in Q1FY26, suggesting improved product mix efficiency even as volume or pricing pressures impacted overall sales.

What the Numbers Show

A notable divergence exists between gross profit growth and net profit decline. While gross profit increased 12% to ₹465.78 Mn, operating expenses rose sharply. Employee expenses grew 8% to ₹137.13 Mn, and other expenses jumped 22% to ₹233.10 Mn. Additionally, finance costs increased 19% to ₹45.10 Mn. These rising operational and financial costs offset the gross margin expansion, leading to the 33% drop in profit before tax (PBT) to ₹31.55 Mn. Other income contributed ₹8.85 Mn, down 5% from the prior year, further limiting bottom-line support.

Business Strategy & Segment Mix

Indogulf Cropsciences emphasized its shift from standalone products to an integrated agri-solutions platform. In Q1FY27, crop protection accounted for 87% of revenue, while biologicals and plant nutrients each contributed 3%. The remaining 7% came from other segments. The company is focusing on expanding high-margin biologicals and specialty products to improve portfolio quality. Export revenues constituted 13% of total sales, supported by new market entries in Venezuela, Taiwan, and Sri Lanka.

Balance Sheet & Operational Outlook

As of FY26, the company’s total equity stood at ₹4,593 Mn, up significantly from ₹2,753 Mn in FY25. Non-current borrowings decreased to ₹30 Mn from ₹357 Mn, indicating debt reduction efforts. Current liabilities totaled ₹3,476 Mn, while current assets were ₹6,648 Mn, providing a comfortable working capital position. Inventories rose to ₹3,435 Mn from ₹2,700 Mn, potentially reflecting stockpiling for future demand or supply chain adjustments.

Looking ahead, Indogulf plans to deepen farmer engagement through its advisory-led model and expand global presence in Africa, Latin America, and Southeast Asia. The multi-brand strategy via AGPL aims to enhance rural penetration and utilize spare manufacturing capacity. With four manufacturing facilities across Haryana and Jammu & Kashmir, the company is positioning itself for scalable growth despite near-term quarterly pressures.